baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC WAR. CALL 06/26 LLY/ DE000HD4LBT4 /

31/05/2024 21:42:00	Chg.0.000	Bid21:59:42	Ask21:59:42	Underlying	Strike price	Expiration date	Option type
5.720EUR	0.00%	5.770 Bid Size: 4,000	5.980 Ask Size: 4,000	ELI LILLY	1,250.00 -	17/06/2026	Call

GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024

GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

GlobeNewswire 24/05 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District

TeleTrader 24/05 Eli Lilly to reveal $5.3B production boost

GlobeNewswire 23/05 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit

GlobeNewswire 23/05 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...

TeleTrader 21/05 Eli Lilly's diabetes drug receives authorization in China

GlobeNewswire 16/05 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 16/05 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 16/05 HEPHAISTOS secures €10.3 M to reach the clinical stage

GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

GlobeNewswire 13/05 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...

GlobeNewswire 09/05 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...

GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 08/05 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

GlobeNewswire 08/05 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...

GlobeNewswire 08/05 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

GlobeNewswire 03/05 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...

GlobeNewswire 01/05 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors

GlobeNewswire 30/04 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

TeleTrader 30/04 Eli Lilly's Q1 revenue surges 26% to $8.8B

UC WAR. CALL 06/26 LLY/ DE000HD4LBT4 /

If you wish to receive reply to your feedback, please provide your email address.